Cigna’s chief executive officer defended the company’s merger with the top U.S. pharmacy benefit manager on Thursday, arguing that the transaction will help the insurer curb growing healthcare costs for corporate clients.

The Bloomfield, Conn.-based company expects the $52 billion merger with Express Scripts to close by the end of 2018, but an ongoing review by the Department of Justice may affect that timeline.